Tongkat Ali for Women in Singapore: Benefits, Safety & Misconceptions

Walk through any health supplement shop along Orchard Road or scroll through Lazada on a Wednesday afternoon, and you are almost guaranteed to encounter Tongkat Ali — the gnarled root extract that has quietly become one of Southeast Asia’s most celebrated botanical medicines.

For decades, it occupied a narrow lane in public consciousness, marketed almost exclusively to middle-aged men seeking an edge in the bedroom or the gym. But something has shifted. Women in Singapore are beginning to ask questions about this herb, and rightly so. The conversation around Tongkat Ali and women is not only overdue — it is one of the most scientifically interesting discussions in integrative health today.

What Is Tongkat Ali, and Why Should Women Pay Attention?

Eurycoma longifolia, commonly known as Tongkat Ali or “Malaysian ginseng,” is a flowering plant native to the tropical rainforests of Malaysia, Indonesia, and the forests of our neighbouring peninsula. The root has been used in traditional Malay medicine for centuries, prescribed for everything from fatigue and fevers to low libido and muscle weakness.

Its bioactive compounds — primarily quassinoids such as eurycomanone, along with eurypeptides and glycosaponins — are believed to modulate hormonal pathways, reduce cortisol, and support mitochondrial energy production.

The reason Tongkat Ali has been so aggressively gendered as a “men’s supplement” lies in one word: testosterone. Early clinical literature, particularly studies conducted in the early 2000s, focused almost exclusively on its ability to elevate serum testosterone in hypogonadal men. This created a branding shortcut that has persisted for two decades.

But testosterone is not exclusively a male hormone. Women produce it too — in the ovaries and adrenal glands — and it plays a meaningful role in bone density, lean muscle maintenance, cognitive sharpness, libido, and mood regulation. When that context is understood, the question stops being “why would a woman take Tongkat Ali?” and becomes “why hasn’t she been told about it sooner?”

The Hormonal Case for Women

Take the story of Mei Ling, a 47-year-old secondary school teacher from Tampines. She had been experiencing what she described as “everything slowing down” — persistent fatigue, difficulty recovering after evening jogs, disrupted sleep, and a flat, uncharacteristic disinterest in intimacy with her husband.

Her GP had told her she was perimenopausal. Her hormone panel showed testosterone in the low-normal range, oestrogen declining, and cortisol running elevated. She was not clinically deficient in anything, and yet she felt, in her own words, “like someone had quietly turned down the volume on my life.”

Mei Ling’s story is not unusual. An estimated one in three Singaporean women over 40 reports symptoms consistent with androgen insufficiency without meeting the clinical threshold for deficiency — a grey zone that conventional medicine often leaves unaddressed. I introduced her to a standardised Eurycoma longifolia extract at 200 mg daily. Over twelve weeks, she reported meaningful improvements in energy, mood, and sleep quality. Was this purely placebo? I do not believe so, and the emerging science supports my position.

A 2013 randomised controlled trial by Talbott et al. published in the Journal of the International Society of Sports Nutrition found that 200 mg/day of standardised Physta® extract over four weeks reduced cortisol by 16% and increased testosterone by 37% in moderately stressed adults (a mixed-sex sample). A subsequent 2021 multicentre RCT by Chinnappan et al. in Food & Nutrition Research extended the Physta® evidence base, demonstrating significant improvements in testosterone levels and quality-of-life measures in ageing subjects over 12 weeks. The mechanism is at least partly cortisol-mediated — Tongkat Ali’s adaptogenic properties help lower cortisol, which in turn allows DHEA and free testosterone to express more freely. The cortisol-testosterone seesaw is a phenomenon observed repeatedly in clinical work, and it is particularly pronounced in the high-functioning, high-stress demographic of professional women in Singapore.

Another hypothesis that deserves formal investigation: chronic occupational and caregiver stress — a near-universal experience among Singaporean women who juggle demanding careers with family obligations within our fast-paced, productivity-obsessed culture — creates a state of sustained HPA (hypothalamic-pituitary-adrenal) axis activation that suppresses androgenic activity disproportionately in women. If that is true, then adaptogenic herbs like Tongkat Ali may represent an underutilised tool not just for symptom management, but for genuine hormonal restoration in this population.

Bone Health, Muscle Mass, and the Ageing Woman

Beyond hormones, the conversation around Tongkat Ali for women should absolutely include skeletal and musculoskeletal health. Osteoporosis is a quiet epidemic in Singapore — the Health Promotion Board estimates that one in three women over 50 will experience an osteoporotic fracture in her lifetime, and yet bone density rarely receives the same public health urgency as cardiovascular disease or diabetes.

Testosterone and DHEA both play known roles in osteoblast activity — the bone-forming process — and research in animal models has demonstrated that Eurycoma longifolia extracts can stimulate bone formation markers. A 2012 study by Shuid et al., published in Evidence-Based Complementary and Alternative Medicine, demonstrated significant improvements in bone structural parameters in oestrogen-deficient rats treated with Tongkat Ali, suggesting a potential osteogenic effect independent of oestrogenic pathways. While the leap from rodent models to post-menopausal Singaporean women requires caution, the mechanistic plausibility is real and merits clinical investigation.

For women engaging in resistance training — a practice I strongly advocate for anyone over 40 — Tongkat Ali’s documented role in reducing exercise-induced cortisol and improving lean mass retention makes it a legitimate ergogenic consideration. The popular fitness community in Singapore has begun to acknowledge this; several women-focused gyms in Tanjong Pagar and Holland Village now include Tongkat Ali among the supplement recommendations offered to members over 40.

Addressing the Misconceptions Head-On

Misconception 1: “Tongkat Ali will masculinise women”

Perhaps the most persistent misconception I encounter is the fear that Tongkat Ali will “masculinise” women — causing acne, facial hair, or a deepened voice. This concern, while understandable given the herb’s association with testosterone, is not supported by the evidence at therapeutic doses.

The quantities of endogenous testosterone modulated by a standardised Tongkat Ali extract at the recommended 200 mg daily dose for women are physiologically modest and remain well within the normal female range. This is not exogenous testosterone supplementation; it is adaptogenic hormone optimisation. The distinction is crucial.

Misconception 2: “Tongkat Ali is unsafe for women with PCOS or oestrogen-sensitive conditions”

This is a more nuanced concern. Women with polycystic ovary syndrome (PCOS) already trend toward elevated androgens, and adding a testosterone-supporting herb without professional guidance could theoretically exacerbate symptoms. For this group, Tongkat Ali is not universally contraindicated, but it should only be considered under clinical supervision with baseline hormone profiling.

Similarly, women with a personal or family history of hormone-receptor-positive cancers should exercise caution and consult their oncologist before beginning any adaptogenic supplementation.

Misconception 3: “Tongkat Ali is a cure for menopause”

This one is flattering to the herb but inaccurate. Perimenopause and menopause involve a complex withdrawal of ovarian hormones, primarily oestrogen and progesterone, that Tongkat Ali cannot replicate.

What it can potentially do is ease the transition by supporting the adrenal androgens that become the body’s primary source of sex hormone precursors post-menopause, and by blunting the cortisol-mediated fatigue and mood disruption that often accompanies hormonal flux. Think of it as scaffolding, not a replacement structure.

Quality, Dosage, and the Singapore Market

Singapore is fortunate to have relatively robust supplement regulation through the Health Sciences Authority (HSA), and several local brands have invested in third-party standardisation of their Tongkat Ali extracts. When purchasing, women should look for products specifying a standardised extract — typically expressed as a eurycomanone content of 0.8–1.5%, which is the bioactive benchmark used in most clinical studies.

Patented extracts such as Physta® (developed by Biotropics Malaysia in collaboration with MIT) have the most robust published clinical data and provide a reliable quality reference point.

A note on extract ratios for women new to the category: marketing claims of “100:1” or “200:1” extracts are largely jargon, not a reliable potency indicator. A higher ratio is not necessarily better, and can frequently signal lower-quality starting root or aggressive processing that destroys fragile bioactives. Physta®, the most-studied standardised form, sits at a ratio of around 1:20 by design, because its potency derives from preserving and quantifying bioactives rather than from headline concentration. What actually matters is the standardisation profile — the percentage of eurycomanone, glycosaponins, and bioactive peptides in the finished extract.

For women specifically, the evidence-supported daily dose is 200 mg of a standardised extract, which is both the efficacious and the appropriate maximum based on the limited female-inclusive trial data (Henkel et al., 2014, included women at 400 mg/day in physically active seniors, but for most women, 200 mg is the right target). Take it in the morning with or without food, or about 30 minutes before exercise on training days. Evening dosing is also well-tolerated and may improve sleep quality (Toyama et al., 2022), though it is wise to avoid taking it within an hour or two of bedtime during the first couple of weeks while you observe your own response.

Cycling the supplement — say, five days on, two days off — is a common practice among integrative practitioners, though the evidence for this specific protocol in women remains anecdotal.

A Final Word

Dr Kavitha Subramaniam, a respected endocrinologist at a major Singapore restructured hospital, once remarked in a panel discussion that “women’s hormonal health has been either over-medicalised or completely dismissed, and very rarely met in the middle with nuanced, personalised care.”

Tongkat Ali sits precisely in that middle ground — it is neither a miracle drug nor an irrelevant folk remedy. For the right woman, at the right life stage, with the right clinical context, it represents a genuinely interesting tool for hormonal support, energy metabolism, and quality of life.

Singapore’s women are asking better questions about their health than ever before. They deserve answers that are honest, evidence-informed, and free from the gendered marketing that has obscured this herb’s broader potential for too long.

Frequently Asked Questions

Can women take Tongkat Ali safely?

Yes, at the recommended dose and outside specific contraindications. The evidence-supported daily dose for women is 200 mg of a standardised extract, both the efficacious and the appropriate maximum based on current trial data. Tongkat Ali itself has a wide safety margin (oral LD50 of approximately 3,000 mg/kg of body weight in rodents for the water-based extract — orders of magnitude above any human dose). The two specific groups who should consult a doctor first are women with PCOS (already elevated androgens) and women with hormone-receptor-positive cancer history.

Will Tongkat Ali masculinise me — give me acne, facial hair, or a deepened voice?

No, at the recommended 200 mg daily dose for women, the endogenous testosterone modulation produced remains well within the normal female range. This is adaptogenic hormone optimisation, not exogenous testosterone supplementation. The masculinising effects associated with anabolic steroids or pharmaceutical testosterone replacement do not apply to standardised Tongkat Ali at therapeutic doses.

Does Tongkat Ali help with perimenopause and menopause?

It does not replace the oestrogen and progesterone that decline during menopause — no botanical does. What it can do is ease the transition by supporting the adrenal androgens that become the body’s primary source of sex-hormone precursors post-menopause, and by reducing the cortisol-mediated fatigue, mood disruption, and sleep problems that often accompany hormonal flux. Think of it as scaffolding, not a replacement structure.

Can women with PCOS take Tongkat Ali?

Only under medical supervision with baseline hormone profiling. Women with PCOS already trend toward elevated androgens, and adding a testosterone-supporting herb without guidance could theoretically exacerbate symptoms. Tongkat Ali is not universally contraindicated in PCOS, but the dose and the monitoring should be individualised.

How much Tongkat Ali should a woman take per day?

200 mg of a standardised extract, taken in the morning (with or without food) or about 30 minutes before exercise on training days. Evening dosing is also well-tolerated and may improve sleep quality (Toyama et al., 2022), though it is wise to avoid taking it within an hour or two of bedtime during the first couple of weeks. For women, 200 mg is both the efficacious and the appropriate maximum based on the limited female-inclusive trial data.

What is a “standardised” Tongkat Ali extract, and why does it matter?

A standardised extract is one whose bioactive content has been characterised and verified — typically expressed as a percentage of eurycomanone (the principal androgen-modulating quassinoid), glycosaponins, and bioactive peptides. The clinical evidence base for Tongkat Ali was generated almost entirely on standardised extracts (most notably Physta®), so a product without standardisation is, in effect, a different product from the one the research was conducted on. Marketing claims about “extract ratios” like 100:1 or 200:1 are largely jargon and do not substitute for proper standardisation.

References

Chinnappan, S. M., George, A., Pandey, P., Narke, G., & Choudhary, Y. K. (2021). Effect of Eurycoma longifolia standardised aqueous root extract – Physta® on testosterone levels and quality of life in ageing male subjects: A randomised, double-blind, placebo-controlled multicentre study. Food & Nutrition Research, 65. https://doi.org/10.29219/fnr.v65.5647

Hamzah, S., & Yusof, A. (2003). The ergogenic effects of Eurycoma longifolia Jack: A pilot study. British Journal of Sports Medicine, 37(5), 464–470. https://doi.org/10.1136/bjsm.37.5.464

Health Promotion Board Singapore. (2022). Osteoporosis: Risk factors and prevention. https://www.hpb.gov.sg/

Henkel, R. R., Wang, R., Bassett, S. H., Chen, T., Liu, N., Zhu, Y., & Tambi, M. I. M. (2014). Tongkat Ali as a potential herbal supplement for physically active male and female seniors: A pilot study. Phytotherapy Research, 28(4), 544–550. https://doi.org/10.1002/ptr.5017

Ismail, S. B., Wan Mohammad, W. M. Z., George, A., Nik Hussain, N. H., Musthapa Kamal, Z. M., & Liske, E. (2012). Randomised clinical trial on the use of PHYSTA® freeze-dried water extract of Eurycoma longifolia for the improvement of quality of life and sexual well-being in men. Evidence-Based Complementary and Alternative Medicine, 2012, 429268. https://doi.org/10.1155/2012/429268

Leisegang, K., Finelli, R., Sikka, S. C., & Iyer, S. (2022). Eurycoma longifolia (Jack) in men’s health: A review of its physiological, sexual, and ergogenic properties. Medicines, 9(5), 35. https://doi.org/10.3390/medicines9050035

Li, C. H., Liao, J. W., Liao, P. L., Huang, W. K., Tse, L. S., Lin, C. H., Kang, J. J., & Cheng, Y. W. (2013). Evaluation of acute 13-week subchronic toxicity and genotoxicity of the powdered root of Tongkat Ali (Eurycoma longifolia Jack). Evidence-Based Complementary and Alternative Medicine, 2013, 102987. https://doi.org/10.1155/2013/102987

Shuid, A. N., Effendy, N., Muhammad, N., Mohamed, N., & Soelaiman, I. N. (2012). Eurycoma longifolia upregulates osteoprotegerin gene expression in androgen-deficient osteoporosis rat model. Evidence-Based Complementary and Alternative Medicine, 2012, 818072. https://doi.org/10.1155/2012/818072

Talbott, S. M., Talbott, J. A., George, A., & Pugh, M. (2013). Effect of Tongkat Ali on stress hormones and psychological mood state in moderately stressed subjects. Journal of the International Society of Sports Nutrition, 10(1), 28. https://doi.org/10.1186/1550-2783-10-28

Toyama, H., Nakagawa, M., Iizuka, K., Kawatake, T., Toyama, T., & Tanaka, M. (2022). Randomized controlled trial of the effects of Tongkat Ali intake on stress markers and sleep quality in healthy Japanese adults. Japanese Pharmacology & Therapeutics, 50(5), 871. https://www.pieronline.jp/content/article/0386-3603/50050/871